These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8369106)

  • 1. Inhibition of type A and B monoamine oxidase by 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines and their N-methylated derivatives.
    Minami M; Maruyama W; Dostert P; Nagatsu T; Naoi M
    J Neural Transm Gen Sect; 1993; 92(2-3):125-35. PubMed ID: 8369106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-(O-benzylphenoxy)-N-methylbutylamine (bifemelane) and other 4-(O-benzylphenoxy)-N-methylalkylamines as new inhibitors of type A and B monoamine oxidase.
    Naoi M; Nomura Y; Ishiki R; Suzuki H; Nagatsu T
    J Neurochem; 1988 Jan; 50(1):243-7. PubMed ID: 3335842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of type A monoamine oxidase by 2(N)-methyl-6,7-dihydroxyisoquinolinium ions.
    Naoi M; Maruyama W; Sasuga S; Deng Y; Dostert P; Ohta S; Takahashi T
    Neurochem Int; 1994 Nov; 25(5):475-81. PubMed ID: 7849576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinoline and quninaldine as naturally occurring inhibitors specific for type A monoamine oxidase.
    Naoi M; Nagatsu T
    Life Sci; 1987 Mar; 40(11):1075-82. PubMed ID: 3821373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of type A monoamine oxidase by methylquinolines and structurally related compounds.
    Naoi M; Nagatsu T
    J Neurochem; 1988 Apr; 50(4):1105-10. PubMed ID: 3346669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,4-Benzoquinone as a new inhibitor of monoamine oxidase.
    Naoi M; Nomura Y; Ishiki R; Suzuki H; Nagatsu T
    Neurosci Lett; 1987 Jun; 77(2):215-20. PubMed ID: 3601232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of type A monoamine oxidase by 1-methyl-4-phenylpyridine.
    Takamidoh H; Naoi M; Nagatsu T
    Neurosci Lett; 1987 Jan; 73(3):293-7. PubMed ID: 3494215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidation of N-methyl-1,2,3,4-tetrahydroisoquinoline into the N-methyl-isoquinolinium ion by monoamine oxidase.
    Naoi M; Matsuura S; Parvez H; Takahashi T; Hirata Y; Minami M; Nagatsu T
    J Neurochem; 1989 Feb; 52(2):653-5. PubMed ID: 2911035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of N-methyl-norsalsolinol on monoamine oxidase of the rat caudate nucleus in vitro.
    Moser A; Scholz J; Bamberg H; Böhme V
    Neurochem Int; 1996 Jan; 28(1):109-12. PubMed ID: 8746770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of monoamine oxidase by 3,4-dihydroxyphenyl L-alanine and its analogues.
    Naoi M; Nagatsu T
    Life Sci; 1987 Jan; 40(4):321-8. PubMed ID: 3100896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.
    Naoi M; Maruyama W; Nagy GM
    Neurotoxicology; 2004 Jan; 25(1-2):193-204. PubMed ID: 14697894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of type A monoamine oxidase by coptisine in mouse brain.
    Ro JS; Lee SS; Lee KS; Lee MK
    Life Sci; 2001 Dec; 70(6):639-45. PubMed ID: 11833714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro inhibition of brain mitochondrial monoamine oxidase by 6-hydroxydopamine.
    Youdim MB
    Br J Pharmacol; 1975 Jul; 54(3):403-5. PubMed ID: 1164597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of brain monoamine oxidase by adducts of 1,2,3,4-tetrahydroisoquinoline with components of cigarette smoke.
    Méndez-Alvarez E; Soto-Otero R; Sánchez-Sellero I; López-Rivadulla Lamas M
    Life Sci; 1997; 60(19):1719-27. PubMed ID: 9129127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of monoamine oxidases A and B by simple isoquinoline alkaloids: racemic and optically active 1,2,3,4-tetrahydro-, 3,4-dihydro-, and fully aromatic isoquinolines.
    Bembenek ME; Abell CW; Chrisey LA; Rozwadowska MD; Gessner W; Brossi A
    J Med Chem; 1990 Jan; 33(1):147-52. PubMed ID: 2296014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type A monoamine oxidase is the target of an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, leading to apoptosis in SH-SY5Y cells.
    Yi H; Akao Y; Maruyama W; Chen K; Shih J; Naoi M
    J Neurochem; 2006 Jan; 96(2):541-9. PubMed ID: 16336631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-methylated tetrahydroisoquinolines as dopaminergic neurotoxins.
    Naoi M; Dostert P; Yoshida M; Nagatsu T
    Adv Neurol; 1993; 60():212-7. PubMed ID: 8420137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantio-specific induction of apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells: suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine.
    Maruyama W; Boulton AA; Davis BA; Dostert P; Naoi M
    J Neural Transm (Vienna); 2001; 108(1):11-24. PubMed ID: 11261742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of monoamine oxidase by palmatine.
    Lee SS; Kim YH; Lee MK
    Arch Pharm Res; 1999 Oct; 22(5):529-31. PubMed ID: 10549584
    [No Abstract]   [Full Text] [Related]  

  • 20. Naturally-occurring isoquinolines perturb monamine metabolism in the brain: studied by in vivo microdialysis.
    Maruyama W; Nakahara D; Dostert P; Takahashi A; Naoi M
    J Neural Transm Gen Sect; 1993; 94(2):91-102. PubMed ID: 7509158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.